|Videos|December 1, 2020
Test Real-World Evidence: Real World Uses and the Regulatory Vision Forward
Author(s)Parexel
Advertisement
Pharm Exec’s Lisa Henderson, Scott Gottlieb, MD, Former FDA Commissioner, and experts from Parexel talk about the COVID-19 pandemic and how its enormous impact on our medical systems has accelerated the growth in and adoption of RWE.
A New Era of Real-World Evidence
Breaking New Ground with RWE
Newsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
New Study Reveals Genetic Predictors for GLP-1 Weight Loss and Side Effects
2
Pharmaceutical Executive Daily: China Approves Amgen's Tarlatamab for Previously Treated Extensive-Stage Small Cell Lung Cancer
3
Amgen’s Tarlatamab Approved in China
4
Aradhana Sarin: The CFO as a Catalyst
5
